Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03563378
Other study ID # 2017-162
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 28, 2018
Est. completion date May 27, 2020

Study information

Verified date June 2018
Source RenJi Hospital
Contact diansan su, Dr.
Phone +862168383702
Email diansansu@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lactated Ringer(LR) has been extensively used to maintain and replace intravascular volume in a variety of anesthetic procedures. However, the utility of LR in pediatric with hepatic failure undergoing liver transplantation is unclear, because addition of exogenous lactate may increase lactate concentration. In addition,large amounts of normal saline(NS) which does not contain lactate can induce a hyperchloremic metabolic acidosis and have been asociated with adverse effects on kidney injury, coagulation, and death. Accordingly, the investigators performed a double-blinded randomized trial comparing the effects of intraoperative NS or LR on outcomes in pediatric receiving Liver transplantation.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 27, 2020
Est. primary completion date May 27, 2020
Accepts healthy volunteers No
Gender All
Age group 3 Months to 6 Years
Eligibility Criteria

Inclusion Criteria:

1. Pediatric patients between the age of 3 month and 6 years

2. Scheduled for living donor liver transplantation

Exclusion Criteria:

1. Re-transplantation

2. Combined liver and kidney transplantation

3. Congenital heart disease

4. Refused to participate the study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Lactated Ringer
Patients will be administered Lactated Ringer's solution for intraoperative fluid management.
Normal saline
Patients will be administered normal saline for intraoperative fluid management.

Locations

Country Name City State
China Renji Hospital Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
RenJi Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in lactate level of the lactated ringer group compared to the normal saline group Baseline serum lactate will be measured after randomization and again after surgery, then every 24 hours for 72 hours up to 3 days after surgery
Secondary Length of mechanical ventilation Length of mechanical ventilation in ICU measured in hours up to 30 days after surgery
Secondary ICU stay Days spend in ICU within 30 days up to 30 days after surgery
Secondary 30 day mortality Patient mortality during the first 30 days after surgery up to 30 days after surgery